Press Release

Megna Health Announces Submission to the FDA for Emergency Use Authorization of its Rapid COVID-19 IgG & IgM Antibody Test for Prescription Home Use

May 25th, 2021

Megna Health Receives Point of Care With Fingerstick, Emergency Use Authorization from the FDA for its Rapid COVID-19 IgM/IgG Combo Antibody Test

April 23rd, 2021

WellTree Molecular Group is an authorized distributor of LifeSign’s groundbreaking cassette-based Rapid COVID + Flu Combo Test with EUA Authorization for use at Point-of-Care settings.

March 17, 2021

WellTree Announces Partnership with Megna Health to Increase Access to Novel IVD Testing

February 4, 2021

WellTree Announces Agreement with Lumos to Increase Access to Novel POC Testing

December 2, 2020